WallStreetZenWallStreetZen

NASDAQ: INVA
Innoviva Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Innoviva earnings were $23.4M for the trailing 12 months ending Dec 31, 2024, with -86.5% growth year over year. The latest INVA earnings report on Dec 31, 2024 announced Q4 2024 earnings of $20.3M, up 1,576.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, INVA reported annual earnings of $23.4M, with -87% growth. The next INVA earnings date is May 6, 2025.

INVA past earnings growth

How has INVA's earnings growth performed historically?

Company
-86.55%
Industry
12.14%
Market
64.34%
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Industry Performance
INVA's earnings have grown slower... subscribe to Premium to read more.
Earnings Growth vs Market Performance
INVA's earnings growth is slowing... subscribe to Premium to read more.
Accelerating Earnings Growth Performance

INVA earnings history

Current Revenue
$358.7M
Current Earnings
$23.4M
Current Profit Margin
6.5%

INVA Return on Equity

Current Company
3.4%
Current Industry
-2%
Current Market
34.1%
INVA's Return on Equity (3.4%)... subscribe to Premium to read more.
High Return on Equity Performance

INVA undefined

Current Company
1.9%
Current Industry
-0.4%
INVA is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INVA announces earnings.

INVA undefined

Current Company
5.6%
Current Industry
5.9%
INVA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INVA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INVA$99.45M$23.39M-24.91%$0.37
IOVA-$331.40M-$372.18MN/A-$1.28
LQDA-$115.24M-$130.39MN/A-$1.66
SNDX-$312.83M-$318.76MN/A-$3.72
ADPT-$123.38M-$159.49MN/A-$1.08
View Top Biotech Stocks

INVA earnings dates

Next earnings date
May 6, 2025

Innoviva Earnings Reports & History FAQ

What were Innoviva's earnings last quarter?

On INVA's earnings call on Invalid Date, Innoviva (NASDAQ: INVA) reported Q4 2024 earnings per share (EPS) of $0.32, up 66.67% year over year. Total INVA earnings for the quarter were $20.33 million. In the same quarter last year, Innoviva's earnings per share (EPS) was $0.96.

If you're new to stock investing, here's how to buy Innoviva stock.

When does Innoviva report earnings?

The next INVA earnings call is Invalid Date. Add INVA to your watchlist to be reminded of Innoviva's next earnings date.

What was INVA's earnings growth in the past year?

As of Innoviva's earnings date in Invalid Date, Innoviva's earnings has grown -86.55% year over year. This is 98.69 percentage points lower than the US Biotechnology industry earnings growth rate of 12.14%. INVA earnings in the past year totalled $23.39 million.

Is Innoviva profitable or losing money?

As of the last Innoviva earnings report, Innoviva is currently profitable. Innoviva's net profit (also called net income) for the twelve months ending Dec 31, 2024 was $23.39 million, a 86.98% decrease year over year.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.